Skip to main content

COVID-19 & cancer


12-05-2021 | COVID-19 | News

COVID-19 leaves large cancer screening deficit in USA

Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.

29-04-2021 | COVID-19 | News

Single COVID-19 vaccine dose insufficient for people with cancer

The booster dose of the Pfizer–BioNTech COVID-19 vaccine should not be delayed in people with cancer, suggest the results of two studies showing insufficient immunogenicity with just the first dose.

21-04-2021 | Telehealth | News

Telemedicine not favored by cancer patients or physicians

The majority of patients with cancer and their physicians report a preference for in-person visits rather than telemedicine consultations, suggest results of a survey carried out at the start of the COVID-19 pandemic.

More on COVID-19 in cancer patients

More guidance for oncologists

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

Image Credits